Crispr Therapeutics shares tumble after significant earnings miss
Investing.com -- Verisk Analytics Inc (NASDAQ:VRSK) shares jumped 3% premarket after the data analytics provider reported second-quarter earnings that exceeded analyst expectations and raised its full-year revenue outlook.
The company posted adjusted earnings per share of $1.88 for the quarter ended June 30, beating the analyst estimate of $1.77. Revenue came in at $773 million, surpassing the consensus estimate of $768.74 million and representing a 7.8% increase from $717 million in the same quarter last year.
"Verisk delivered another strong quarter of broad-based growth in the second quarter and we are raising our revenue and adjusted EBITDA outlook for the full year 2025," said Lee Shavel, President and CEO of Verisk.
The company’s underwriting segment, which includes forms, rules and loss cost services, saw revenue increase 8.3% to $550 million. Claims revenue grew 6.6% to $223 million, driven primarily by growth in property estimating solutions and anti-fraud solutions.
Adjusted EBITDA increased 11.9% to $445 million, with margins improving to 57.6% from 55.4% in the prior-year period. Free cash flow rose 22.6% to $188.7 million.
For the full year 2025, Verisk raised its revenue guidance to $3.09-3.13 billion from its previous forecast of $3.03-3.08 billion, now above the analyst consensus of $3.079 billion. The company also increased its adjusted EBITDA outlook to $1.7-1.74 billion while maintaining its adjusted EBITDA margin forecast of 55.0-55.8%.
However, Verisk slightly lowered the high end of its full-year EPS guidance to $6.80-7.00 from the previous $6.80-7.10, below the analyst consensus of $7.05.
"We are investing our capital in core operations and in acquisitions of strong and strategic businesses where we can create value with attractive returns consistent with our capital discipline, while also returning capital to shareholders," said Elizabeth Mann, CFO of Verisk.
During the quarter, Verisk completed a $100 million accelerated share repurchase program, resulting in the repurchase of 0.3 million shares at an average price of $309.58.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.